Takeover of NxStage Medical, Inc. (NASDAQ:NXTM) Under Investigation for Investors
An investigation was announced for investors, who currently hold NASDAQ:NXTM shares, concerning whether the takeover of NxStage Medical, Inc. by Fresenius Medical Care for $30.00 per share is unfair to NASDAQ:NXTM stockholders.
View full press release